96 Bevacizumab-Based Anti-Tumoral Therapy Does Not Increase the Risk of Bowel Perforation in Patients With Metastatic Obstructive Colorectal Cancer Palliated With Self-Expanding Metallic Stents. Results of a Prospective Study

Authors :: Giovanni Rossi
Paolo Delrio
Cristina Bucci
Daniela Rega
Guglielmo Nasti
Andrea Belli
Mario De Bellis
Elena Di Girolamo
F. Bianco
Leonardo Frazzoni
Valeria Vicario
Antonio Avallone
Lorenzo Fuccio
Source :: Gastrointestinal Endoscopy. 81:AB111
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: medicine.medical_specialty
Bevacizumab
Colorectal cancer
business.industry
Gastroenterology
Bowel perforation
medicine.disease
Surgery
medicine
Radiology, Nuclear Medicine and imaging
In patient
Prospective cohort study
business
medicine.drug

Full Text Access

Tools